| APSAC | acylated plasminogen-streptokinase activator complex; anisoylated plasminogen streptokinase activato... |
|---|---|
| APSAC | 1) Acylating the Plasminogen Streptokinase Activated Complex 2) Anisoylat... |
| rt-PA | recombinant tissue-Plasminogen Activator = Alteplase |
| tPA | tissue Plasminogen Activator |
| EPA | eicosapentaenoic acid; empiric phrase association; Environmental Protection Agency; erect posterior-... |
| APSAC | Anisoylated Plasminogen Streptokinase Activator Complex |
|---|---|
| PA | Plasminogen Activator |
| PAA | Plasminogen Activator Activity |
| PAI 1 | Plasminogen Activator Inhibitor type 1 |
| PAI | Plasminogen Activator Inhibitors |
| plasminogen activator | <enzyme> Serine protease that acts on plasminogen to generate plasmin. Has also been implicated in invasiveness and is produced by many normal and invasive cells. The vascular form (tPA, 55 kD) is very similar to tissue plasminogen activator (uPA, 70 kD) and to streptokinase and urokinase. (18 Nov 1997) |
|---|---|
| plasminogen activator inhibitor 1 | <chemical> A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activator. Pharmacological action: serine proteinase inhibitors. (12 Dec 1998) |
| plasminogen activator inhibitor 2 | <chemical> Member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activator. Pharmacological action: serine proteinase inhibitors. (12 Dec 1998) |
| tissue plasminogen activator | <enzyme> Plasma serine protease, one of a closely related group of plasminogen activators. Contains an EGF like domain and multiple copies of the kringle domain. (18 Nov 1997) |
|---|---|
| kidney plasminogen activator | <protein> A precursor to the enzyme urokinase that has blood clotting properties. (14 Nov 1997) |
| plasminogen | <enzyme> The inactive precursor of plasmin. (18 Nov 1997) |
| plasminogen inactivators | <chemical> Important modulators of the activity of plasminogen activator. Four inhibitors, all belonging to the serpin family of proteins, have been implicated in plasminogen activation inhibition. They are pai-1, pai-2, protease-nexin, and protein c inhibitor (pai-3). All inhibit both the tissue-type and urokinase-type plasminogen activator. Pharmacological action: serine proteinase inhibitors. (12 Dec 1998) |
| activator | <biochemistry> A DNA-binding transcription metabolite that positively modulates an allosteric enzyme or regulates one or more genes by increasing the rate of transcription. (12 Mar 1998) |
| activator appliances | Loose-fitting removable orthodontic appliances which redirect the pressures of the facial and masticatory muscles onto the teeth and their supporting structures to produce improvements in tooth arrangements and occlusal relations. (12 Dec 1998) |
| catabolite gene activator | catabolite (gene) activator protein |
| catabolite gene activator protein | <molecular biology, protein> A regulatory protein that triggers the transcription of genes that generate the enzymes bacteria need to usenutrients when glucose isabsent. (16 Mar 1998) |
| catabolite (gene) activator protein | A protein that can be activated by cAMP, whereupon it affects the action of RNA polymerase by binding it with it or near it on the DNA to be transcribed. Synonym: cAMP receptor protein, catabolite gene activator. (05 Mar 2000) |
| polyclonal activator | A substance that will activate T-cells, B-cells, or both regardless of their specificities. (05 Mar 2000) |
| protein activator, aminolevulinic acid synthetase | <chemical> From rat liver mitochondria Synonym: aminolevulinic acid synthetase activator (26 Jun 1999) |
Synonyms : Type 1 Plasminogen Activator Inhibitor
Synonyms : Type 2 Plasminogen Activator Inhibitor
Synonyms : Extrinsic Plasminogen Activators, Plasminogen Activator, Uterine-Tissue Plasminogen Activator, Uterine Tissue Plasminogen Activator
| plasminogen activator |
protease produced in the kidney that converts plasminogen to plasmin and so initiates fibrinolysis
출처: wordnet.princeton.edu/perl/webwn
|
|---|---|
| plasminogen activator |
a general term for a group of substances that have the ability to cleave plasminogen and convert it into plasmin, its active form; see t-plasminogen a. and u-plasminogen a.
출처: www.merckmedicus.com/pp/us/hcp/thcp_dorlands_conte...
|
| plasminogen activator inhibitor-1 |
A protein that degrades extracellular tissues. It has been linked to the invasive and metastatic spread of cancers.
출처:
|
| plasminogen activator i. |
any of several regulators of the fibrinolytic system that act by binding to and inhibiting free plasminogen activator. The concentration in plasma of the inhibitors is normally low, but is altered in some disturbances of the hemostatic system. PAI-1 is an important fast-reacting inhibitor of t-PA and u-PA. Its synthesis, activity, and release are highly regulated. Elevated levels of the inhibitor have been described in a number of disease states. PAI-2 is a normally minor inhibitor that greatly increases in concentration during pregnancy and in certain disorders. PAI-3 is protein C inhibitor.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| plasminogen activator | protease produced in the kidney that converts plasminogen to plasmin and so initiates fibrinolysis |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|